Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

PHASE3CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

March 11, 2015

Primary Completion Date

October 28, 2019

Study Completion Date

May 14, 2020

Conditions
Influenza
Interventions
DRUG

Peramivir

DRUG

Oseltamivir

Trial Locations (10)

Unknown

Peramivir Investigative Site, Shreveport

Peramivir investigative site, Dayton

Peramivir investigative site, Smithfield

Peramivir Investigative Site, Houston

Peramivir investigative site, San Antonio

Peramivir investigative site, Splendora

Peramivir investigative site, Draper

Peramivir investigative site, Salt Lake City

Peramivir investigative site, South Jordan

Peramivir Investigative Site, Pretoria

Sponsors
All Listed Sponsors
lead

BioCryst Pharmaceuticals

INDUSTRY

NCT02369159 - Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza | Biotech Hunter | Biotech Hunter